Ramadan Fasting in Diabetes Patients on Insulin Pump Therapy Augmented by Continuous Glucose Monitoring: An Observational Real-Life Study

2012 ◽  
Vol 14 (9) ◽  
pp. 813-818 ◽  
Author(s):  
Ali Bernard Khalil ◽  
Salem A. Beshyah ◽  
Samar M. Abu Awad ◽  
Mahmoud M. Benbarka ◽  
Marcil Haddad ◽  
...  
2015 ◽  
Vol 61 (6) ◽  
pp. 55-78 ◽  
Author(s):  
Marina Vladimirovna Shestakova ◽  
Aleksandr Yuryevich Mayorov ◽  
Yury Ivanovich Philippov ◽  
Lyudmila Ibragimovna Ibragimova ◽  
Elena Vladimirovna Pekareva ◽  
...  

Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) and continuous glucose monitoring (CGM) are high-tech treatment and diagnostic tools for diabetes patients management which are actively used worldwide. CSII initiation and pump-users supervision became a part of routine clinical practice in Russia along with the CGM. Present project of clinical guidelines is based on international and domestic experience in CSII and CGM for diabetes treatment. Guidelines should ensure uniformity of CGM and CSII usage in Russia by health care professionals and diabetes patients and provide them an international experience to guarantee height performance of the technology. This article contains a preliminary version of the guidelines (draft) prepared for further expert’s discussion and review. The final version of the clinical guidelines will be sent to the Ministry of Health of the Russian Federation for approval.


2015 ◽  
pp. 1263 ◽  
Author(s):  
Andrea Tumminia ◽  
Laura Sciacca ◽  
Lucia Frittitta ◽  
Sebastiano Squatrito ◽  
Riccardo Vigneri ◽  
...  

2018 ◽  
Vol 9 (5) ◽  
pp. 157-166 ◽  
Author(s):  
Torben Biester ◽  
Olga Kordonouri ◽  
Thomas Danne

For paediatric patients with type 1 diabetes, intensified insulin therapy with either multiple daily injection or insulin pump therapy is currently the only method of treatment. To optimize this therapy, insulin analogues are fixed parts of all therapy regimens. New ultra-rapid insulins seem to be beneficial not only in adults but also in this age group. New developments in long-acting analogues have demonstrated safety and will be regular in paediatrics, we hope, soon. Furthermore, the psychosocial approach for consideration of real-life aspects becomes more the focus of therapeutic regimens and is implemented into international guidelines. Technical improvements, such as continuous glucose monitoring, particularly in combination with pump therapy, support the great success of rapid-acting analogues by reducing hypoglycaemias. Non-insulin agents such as SGLT2-inhibitors show beneficial aspects in people with type 1 diabetes. For outpatient care with these currently off-label-used drugs, special training for measurement of ketones should be imperative.


2010 ◽  
Vol 89 (9) ◽  
pp. 1233-1237 ◽  
Author(s):  
Anna L. Secher ◽  
Signe Schmidt ◽  
Kirsten Nørgaard ◽  
Elisabeth R. Mathiesen

Sign in / Sign up

Export Citation Format

Share Document